T32 MH019552/MH/NIMH NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	1
2003	1
2005	1
2009	2
2010	2
2011	1
2024	0

1

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.

Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL, Hamilton SP. Garriock HA, et al. Am J Psychiatry. 2010 May;167(5):565-73. doi: 10.1176/appi.ajp.2009.08081167. Epub 2010 Mar 1. Am J Psychiatry. 2010. PMID: 20194481 Free PMC article.

2

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM, Garriock HA, Yokoyama JS, McGrath PJ, Peters EJ, Scheftner WA, Coryell W, Lawson WB, Jancic D, Gejman PV, Sanders AR, Holmans P, Slager SL, Levinson DF, Hamilton SP. Shyn SI, et al. Mol Psychiatry. 2011 Feb;16(2):202-15. doi: 10.1038/mp.2009.125. Epub 2009 Dec 29. Mol Psychiatry. 2011. PMID: 20038947 Free PMC article.

3

A genomewide association study of citalopram response in major depressive disorder.

Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD, Reinalda MS, Slager SL, McGrath PJ, Hamilton SP. Garriock HA, et al. Biol Psychiatry. 2010 Jan 15;67(2):133-8. doi: 10.1016/j.biopsych.2009.08.029. Biol Psychiatry. 2010. PMID: 19846067 Free PMC article.

4

Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function.

Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, Carra S, Pierucci M, Di Giovanni G, Esposito E, Parsons LH, Bonci A, Tecott LH. Abdallah L, et al. J Neurosci. 2009 Jun 24;29(25):8156-65. doi: 10.1523/JNEUROSCI.3905-08.2009. J Neurosci. 2009. PMID: 19553455 Free PMC article.

5

D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.

Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S, Axelrod JD, Cheyette BN, Simon MI, Lester HA, Schwarz J. Kovoor A, et al. J Neurosci. 2005 Feb 23;25(8):2157-65. doi: 10.1523/JNEUROSCI.2840-04.2005. J Neurosci. 2005. PMID: 15728856 Free PMC article.

6

Neurotrophin-regulated sorting of opioid receptors in the biosynthetic pathway of neurosecretory cells.

Kim KA, von Zastrow M. Kim KA, et al. J Neurosci. 2003 Mar 15;23(6):2075-85. doi: 10.1523/JNEUROSCI.23-06-02075.2003. J Neurosci. 2003. PMID: 12657666 Free PMC article.

7

Morphine-activated opioid receptors elude desensitization by beta-arrestin.

Whistler JL, von Zastrow M. Whistler JL, et al. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9914-9. doi: 10.1073/pnas.95.17.9914. Proc Natl Acad Sci U S A. 1998. PMID: 9707575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year